Pneumocystis: Clinical Trials

12 trials for Pneumocystis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 recruiting, 2 not yet recruiting, 1 enrolling by invitation. 3 Phase 3, 2 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Recruiting 1, Unknown 1
Not applicable2Completed 1, Enrolling by invitation 1
Phase 42Not yet recruiting 2

Follow Pneumocystis: new trials by email Literature Review of Pneumocystis trials Research Report on Pneumocystis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)
Clindamycin + primaquine, Pentamidine, Atovaquone - Pneumocystis, Pneumocystis Infection
Phase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre4162026-03-012026-01-21
How Long Should we Give Steroids for Patients With Severe PCP
Systemic corticosteroids - Pneumocystis Pneumonia, Pneumocystis
Phase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre4162026-01-302026-01-09
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
trimethoprim-sulfamethoxazole - Pneumocystis, Pneumocystis Pneumonia
Phase 3RecruitingTodd C. Lee MD MPH FIDSA4162025-11-282026-02-20
Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia
RecruitingAzienda Ospedaliero-Universitaria Careggi4002025-11-132026-07-02
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
Biological sampling - Pneumocystis, Immunocompromised Patients
RecruitingAssistance Publique - Hôpitaux de Paris2402025-07-082026-04-23
Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
Pneumocystis Jirovecii Infection, Pneumocystis
CompletedUniversity of Colorado, Denver120322023-07-052025-04-02
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Rezafungin for Injection, Posaconazole, Fluconazole - Candidemia, Mycoses
Phase 3CompletedMundipharma Research Limited6022020-05-112026-04-13
Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS
Conventional steroid regimen, Shortened steroid regimen - Pneumocystis, HIV/AIDS
Not applicableEnrolling by invitationCentro de Investigación en. Enfermedades Infecciosas, Mexico1962019-03-042026-03-27
Non Invasive Diagnosis of Pneumocystis Pneumonia
Sampling of non-invasive and/or non-targeted respiratory tract specimens - Pneumocystis
Not applicableCompletedUniversity Hospital, Grenoble982018-06-252023-03-24
Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients
Methylprednisolone, Placebo - Pneumocystis, Steroids
Phase 3UnknownAssistance Publique - Hôpitaux de Paris2222017-02-152020-10-06
Pneumocystis in Patients Over 75 Year
Pneumocystis
CompletedCentre Hospitalier Universitaire de Nīmes1622010-01-012025-06-04
Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center
HIV Infections, Emphysema
CompletedUniversity of Pittsburgh4072009-01-012025-08-26

Narrower conditions

Pneumonia, Pneumocystis (12)  ·  Infections (4)  ·  Pneumocystis Infections (4)  ·  Pneumonia (4)  ·  Candidiasis (2)  ·  Mycoses (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Aspergillosis (1)  ·  Candidemia (1)  ·  Candidiasis, Invasive (1)  ·  Coinfection (1)  ·  Communicable Diseases (1)  ·  Community-Acquired Pneumonia (1)  ·  Cryptococcosis (1)  ·  Emergencies (1)

Broader conditions

Bacterial Infections and Mycoses (12)  ·  Lung Diseases (12)  ·  Lung Diseases, Fungal (12)  ·  Respiratory Tract Diseases (12)  ·  Respiratory Tract Infections (11)  ·  Mycoses (10)  ·  Infections (8)  ·  Pneumocystis Infections (8)  ·  Pneumonia (8)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Disease Attributes (2)  ·  Genital Diseases (2)  ·  Immune System Diseases (2)

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination (2)  ·  Atovaquone (1)  ·  Clindamycin (1)  ·  Costs and Cost Analysis (1)  ·  Fluconazole (1)  ·  Injections (1)  ·  Methylprednisolone (1)  ·  Off-Label Use (1)  ·  Pentamidine (1)  ·  Primaquine (1)  ·  Rezafungin (1)  ·  posaconazole (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (2)  ·  Azienda Ospedaliero-Universitaria Careggi (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Centro de Investigación en. Enfermedades Infecciosas, Mexico (1)  ·  Mundipharma Research Limited (1)  ·  Todd C. Lee MD MPH FIDSA (1)  ·  University Hospital, Grenoble (1)  ·  University of Colorado, Denver (1)  ·  University of Pittsburgh (1)

Countries

France (5)  ·  Canada (3)  ·  United States (3)  ·  Italy (2)  ·  Belgium (1)  ·  Germany (1)  ·  Mexico (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Emily G McDonald, MD MSc (2)  ·  Alison Morris-Gimbel, MD (1)  ·  Elie Azoulay, MD PHD (1)  ·  Gustavo Reyes-Teran, M.D. (1)  ·  Laura Cox, PhD (1)  ·  Lorenzo Pelagatti, MD, PhD (1)  ·  Matthew P Cheng, MD FRCPC (1)  ·  Todd C Lee, MD MPH (1)  ·  Todd C Lee, MD MPH FIDSA (1)  ·  Virginie Lemiale, MD (1)

Results publications

PMID 25603113, PMID 32479781, PMID 33005696, PMID 33438477, PMID 34349985, PMID 34988242, PMID 35657109, PMID 35863836, PMID 37773627, PMID 38235979, PMID 40652952, PMID 42558999

NIH funding

2016 (1), 2017 (1), R01HL090339 (1)